InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Frustrated post# 162050

Thursday, 02/20/2014 3:13:26 PM

Thursday, February 20, 2014 3:13:26 PM

Post# of 346050
because they have been talking partnership for the past two years and the amendment filing had details... legally binding details... that the partner was "Abbott" last Sept 2012 so you trying to say that with improved understanding of Bavi MOA and continued trials and 4 new KOL's and March Madness...etc..etc..

that there is "LESS" interest now? Please be real... this is not some soul searching for a drug that may work... Peregrine has proven it beyond a reasonable doubt and they also have "clear evidence of dose switching" as probably again, beyond a reasonable doubt.

Today.. tomorrow, next week... of whatever, its clear the Ides of March are upon us.


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News